Upashita IV injection for dialysis 250μg syringe, manufactured by Sanwa Chemical Research Institute, contains Upacicalcet sodium hydrate. This calcimimetic agent works by increasing the sensitivity of calcium-sensing receptors on the parathyroid glands to reduce parathyroid hormone secretion in patients on hemodialysis. It is supplied as a 250μg/1mL/1 tube injectable drug (YJ code: 3999460G6023).
Upashita IV injection for dialysis 250μg syringe
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →